| Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Kunzler Jacqueline | SVP, Chief Quality Officer | Sep 05 | Sale | 88.12 | 5,934 | 522,904 | 3,089 | Sep 06 04:15 PM | | GAVIN JAMES R III | Director | Aug 19 | Option Exercise | 33.18 | 7,950 | 263,805 | 44,862 | Aug 20 04:06 PM | | GAVIN JAMES R III | Director | Aug 19 | Sale | 87.63 | 7,950 | 696,659 | 36,912 | Aug 20 04:06 PM | | Kunzler Jacqueline | SVP, Chief Quality Officer | Jun 19 | Sale | 80.46 | 593 | 47,713 | 9,023 | Jun 20 04:01 PM | | FORSYTH JOHN D | Director | Jun 13 | Option Exercise | 24.27 | 1,320 | 32,036 | 32,779 | Jun 14 04:02 PM | | FORSYTH JOHN D | Director | Jun 13 | Sale | 78.21 | 1,320 | 103,237 | 31,459 | Jun 14 04:02 PM | | Third Point LLC | Director | May 16 | Sale | 76.37 | 5,000,000 | 381,850,000 | 23,008,125 | May 17 05:08 PM | | STALLKAMP THOMAS T | Director | May 01 | Sale | 76.20 | 1,000 | 76,200 | 4,737 | May 03 04:09 PM | | HELLMAN PETER S | Director | Apr 01 | Option Exercise | 26.78 | 5,680 | 152,110 | 28,774 | Apr 03 05:30 PM | | STROUCKEN ALBERT P L | Director | Apr 01 | Option Exercise | 26.78 | 5,680 | 152,110 | 32,965 | Apr 03 05:33 PM | | STROUCKEN ALBERT P L | Director | Apr 01 | Sale | 81.89 | 5,680 | 465,135 | 27,285 | Apr 03 05:33 PM | | STALLKAMP THOMAS T | Director | Apr 01 | Sale | 82.07 | 1,043 | 85,599 | 5,737 | Apr 03 05:31 PM | | HELLMAN PETER S | Director | Apr 01 | Sale | 81.89 | 5,680 | 465,135 | 23,094 | Apr 03 05:30 PM | | Pleau Scott | SVP, Operations | Mar 29 | Option Exercise | 50.77 | 9,710 | 492,977 | 29,786 | Apr 02 04:05 PM | | Pleau Scott | SVP, Operations | Mar 29 | Sale | 80.00 | 9,710 | 776,800 | 20,076 | Apr 02 04:05 PM | | Accogli Giuseppe | SVP, President, Global Bus. | Mar 18 | Option Exercise | 40.24 | 38,297 | 1,541,199 | 96,963 | Mar 20 04:59 PM | | Accogli Giuseppe | SVP, President, Global Bus. | Mar 18 | Sale | 76.78 | 38,297 | 2,940,444 | 58,666 | Mar 20 04:59 PM | | FORSYTH JOHN D | Director | Mar 13 | Option Exercise | 24.27 | 1,500 | 36,405 | 31,703 | Mar 15 04:24 PM | | FORSYTH JOHN D | Director | Mar 13 | Sale | 75.92 | 1,500 | 113,880 | 30,203 | Mar 15 04:24 PM | | STALLKAMP THOMAS T | Director | Mar 01 | Sale | 75.16 | 1,000 | 75,160 | 6,780 | Mar 04 05:07 PM | | STALLKAMP THOMAS T | Director | Jan 18 | Sale | 70.00 | 3,187 | 223,090 | 9,418 | Jan 23 05:36 PM | | FORSYTH JOHN D | Director | Dec 13 | Option Exercise | 24.27 | 1,500 | 36,405 | 31,640 | Dec 17 04:18 PM | | Shapazian Carole J | Director | Dec 13 | Option Exercise | 39.83 | 4,110 | 163,701 | 13,958 | Dec 17 04:21 PM | | Shapazian Carole J | Director | Dec 13 | Sale | 66.69 | 4,110 | 274,096 | 9,848 | Dec 17 04:21 PM | | FORSYTH JOHN D | Director | Dec 13 | Sale | 67.02 | 1,500 | 100,530 | 30,140 | Dec 17 04:18 PM | | Shapazian Carole J | Director | Dec 03 | Option Exercise | 41.23 | 11,749 | 484,408 | 21,597 | Dec 06 05:17 PM | | Shapazian Carole J | Director | Dec 03 | Sale | 68.48 | 11,749 | 804,572 | 9,848 | Dec 06 05:17 PM | | Third Point LLC | Director | Dec 03 | Sale | 68.62 | 8,000,000 | 548,960,000 | 28,008,125 | Dec 04 05:12 PM | | Accogli Giuseppe | SVP, President, Global Bus. | Sep 17 | Option Exercise | 42.56 | 17,647 | 751,138 | 67,785 | Sep 19 05:42 PM | | Eyre Brik V | SVP, President, Americas | Sep 17 | Option Exercise | 38.18 | 71,643 | 2,735,345 | 137,005 | Sep 19 05:43 PM | | Eyre Brik V | SVP, President, Americas | Sep 17 | Sale | 77.31 | 78,012 | 6,031,108 | 58,993 | Sep 19 05:43 PM | | Accogli Giuseppe | SVP, President, Global Bus. | Sep 17 | Sale | 77.27 | 17,647 | 1,363,584 | 50,138 | Sep 19 05:42 PM |
|
